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Background: The microbiota colonizing dental implants
has been said to be similar to the microbiome surrounding
teeth. In the absence of inflammation, a biofilm with patho-
logic bacteria can cover implant surfaces exposed to the
oral cavity, for example, due to a remodeling process. The
aim of the present study is to identify microbiota surrounding
exposed dental implants in patients with and without a history
of periodontitis through a deep-sequencing approach.
Methods: An experimental abutment with the same sur-
face and structure as a commercially available dental im-
plant was used. Bacterial DNA was isolated, and the 16S
ribosomal RNA gene was amplified and sequenced. Multi-
plexed tag-encoded sequencing of DNA from the samples
was performed, and the reads were processed by metage-
nomic rapid annotation.
Results: A wide variety of bacteria, 96 species, were iden-
tified. The most frequently found bacteria were Fusobacte-
rium nucleatum and Prevotella denticola. Some species
generally associated with periodontitis were found to a great-
er extent in patients without a history of periodontitis. Some
bacteria that have never been described as part of the oral
microbiome were identified in the present sample.
Conclusions: Analysis of data suggests that the bacteria
surrounding exposed dental implants form a diverse micro-
biome regardless of the periodontal profile of patients. Further
research is needed to clarify the role of these microorganisms
in the oral environment. J Periodontol 2017;88:1090-1104.
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O
sseointegrated dental implants
have become an important al-
ternative for replacing missing
teeth. Despite high survival and success
rates of dental implants, biologic com-
plications, mainly peri-implant mucosi-
tis and peri-implantitis, are a growing
concern. It is estimated that 12% to 22% of
patients with implants will be diagnosed
with peri-implantitis within a short-term
follow-up (5 years).1
Peri-implantitis is considered an in-
fectious chronic disease that starts with
the formation of a heterogeneous biofilm
community.2 Recent findings suggest
a model of pathogenesis in which peri-
odontitis is initiated by a broadly based,
dysbiotic, synergistic microbiota,3 as
opposed to the traditional view of a con-
ventional infectious disease caused by one
or more periopathogens such as the ‘‘red
complex.’’4 This could also be the case
with peri-implant diseases.5 The micro-
biota colonizing implants is still poorly
known, and its differences from biofilms
around teeth need further investigation. In
fact, due to the macrostructure and sur-
face characteristics of implants, biofilm
content can be quite different and can
favor the presence of pathologic bacteria
even in absence of peri-implant diseases.
To the authors’ knowledge, no data have
been published on microbiota formed in
patients whose implants have become
exposed to the oral cavity due to soft tissue
recession but who have no inflammation.
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This knowledge is essential to prevent initiation and
progression of peri-implant diseases.
A number of methods have been used to study the
microbiota surrounding dental implants.6-8 Samples
have been collected by rubbing or scratching im-
plants with sterile paper points, curets, or periodontal
probes. These procedures recover some of the bacteria
but may fail to identify microorganisms that remain
firmly attached to the implant surface. Recovering the
entire biofilm on exposed implants would be of great
value, but this is only possible when the implant is
retrieved (i.e., in advanced cases that can only be
treated by explantation). A removable abutment
mimicking the macrostructure and microstructure of
an implant would make it possible to recover an intact
biofilm similar to that covering an exposed implant.
Another very important limitation of most studies on
this issue is that their techniques, such as oligonu-
cleotide probes, polymerase chain reaction (PCR), and
checkerboard DNA–DNA hybridization, do not allow
massive bacterial sequencing.6,9-11 Pyrosequencing
provides amore complete view of the oralmicrobiome.
Using metagenomic techniques and next-generation
sequencing technology, the total DNA pool in complex
microbiologic samples can be analyzed. This method
can detect most species and identify bacteria that
cannot be cultivated by standard techniques.
The hypothesis that microbiota colonizing the
surface of experimental abutments mimicking ex-
posed dental implants without peri-implant diseases
contain a large number of bacterial species, with
predominance of Gram-negative bacteria and with
differences among patients with and without a previous
history of periodontitis, is presented. Therefore, the
present study identifies the microbiome formed on
abutments that simulate exposed dental implants using
pyrosequencing and compares the bacteria of healthy
patients and patients with a history of periodontitis.
MATERIALS AND METHODS
Patient Recruitment
The experimental non-randomized study consisted of
10 individuals (six males and four females, aged 45
to 84 years; mean age: 60.7 years) with at least one
healthy osseointegrated dental implant with a hex-
agonal external connection, of whom five had a his-
tory of periodontitis (periodontitis group, PG), and
five were periodontally healthy (healthy group, HG).
Patients were defined as periodontally healthy
when they had no attachment loss (AL), no bone loss
(BL) measured in periapical radiographs, probing
depth (PD) of <4 mm, and no bleeding on probing
(BOP) for at least 70% of sites. They were considered
to have history of periodontitis when they presented
AL ‡1mmat >30% of sites and evidence of BL. It should
be pointed out that all patients in PG had been treated,
and the disease was under control when they were
enrolled in the present trial. All patients met the fol-
lowing inclusion criteria: 1) aged 18 to 90 years; 2)
American Society of Anesthesiologists (ASA) health
status score12 £3; 3) osseointegrated implants with
hexagonal external connection; 4) not having received
final prosthesis; 5) gingival height of 2mm from implant
shoulder to gingivalmargin; and 6) sufficient intellectual
capacity to understand the study. Study protocol was
approved by the Institutional Review Board (Clinical
Research Ethics Committee; protocol number 05/14),
Dental Hospital, University of Barcelona, Barcelona,
Spain, and complied with the Helsinki Declaration of
1975 as revised in 2013. All patients gave written in-
formed consent to participate in the study.
Patients were excluded in the following situations: 1)
generalized gingivitis with BOP at >30% of sites; 2)
uncontrolled periodontal disease (PD ‡5 mm with
bleeding and/or suppuration); 3) peri-implant disease
(implants with bleeding and/or suppuration, and at least
one site with radiographic evidence of BL ‡2 mm); 4)
any periodontal treatment in the 30 days prior to en-
rollment; or 5) use of antibiotic or antiseptic mouthrinse
(bisbiguanides, quaternary ammonium salts, and es-
sential oils) in the 30 days prior to enrollment.
Data Sampling
A single researcher (BC-A) recruited the patients from
February to September 2014 at the Dental Hospital of
the University of Barcelona, Hospitalet de Llobregat
(Barcelona, Spain) and examined all clinical records.
Data retrieved were age, sex, patient health status
based on the ASA Physical Status Classification
System,12 systemic pathologies, current medication,
smoking habit (number of cigarettes per day), peri-
odontal disease (periodontal chart with recessions,
PD, BOP, and suppuration), and the following implant
variables: 1) date of implant placement; 2) diameter;
3) length; 4) position; 5) distance from any nearby
implants; 6) width of keratinized mucosa; 7) type of
prosthesis; 8) Mombelli peri-implant plaque index
(PPI);13 9) Mombelli peri-implant sulcus bleeding in-
dex (PSBI);13 10) suppuration; 11) peri-implant PD;
and 12) BL. BL was measured on digital periapical
radiographs using image processing software.i14
Sample Collection and DNA Isolation
The abutments used, specifically fabricated for this
purpose, were designed to have the samemacroscopic
and microscopic shape as an implant with a bio-
absorbable blast media surface¶ (see supplementary
Fig. 1 in online Journal of Periodontology).
After a thorough explanation of the study objectives,
a healing abutment was replaced by the experimental
i ImageJ software, US National Institutes of Health, Bethesda, MD.
¶ Mozo-Grau dental implants, Mozo-Grau, Valladolid, Spain.
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abutment (see supplementary Fig. 1 in online Journal
of Periodontology). Patients were instructed to refrain
from cleaning the abutment and using toothpaste or
mouthrinse solutions during the study period.
After 14 days, the experimental abutment was
carefully removed, placed in a sterile snap-cap tube,
and transported to the laboratory in <1 hour in
a portable refrigerator at 4C. The abutment was
screwed to an implant analog placed inside the tube,
allowing the biofilm to remain intact without touching
the tube wall.
All patients were enrolled in a peri-implant main-
tenance program, and a final prosthesis was made.
After the abutment was received at the laboratory,
it was unscrewed, stored in a 1.5-mL microcentrifuge
tube, and frozen at -80C until further analysis. The
abutment was rinsed with phosphate-buffered saline
and vortexed for 5 minutes to release the bacteria.
Total DNA was purified with a DNA purification kit,#
according to the manufacturer’s protocol for buccal
swabs. The amount of DNA extracted was calculated
using a scientific instrumentation system.**
Statistical Analyses
Variable regions V1, V2, V3, V4, and V5 of the 16S
ribosomal RNA (rRNA) gene were amplified with
a multiplex PCR system†† and sequenced with a ti-
tanium sequencing kit.‡‡
PCRs for V1-V3 and V5-V3 primers were set up
with annealing temperatures of 56C and 50C, re-
spectively. Two replicate PCRs were performed and
pooled for each sample. Amplicon library was
cleaned with a PCR purification system,§§ according
to the manufacturer’s instructions. Amplicon con-
centration was estimated using an assay kit.ii
Multiplexed tag-encoded sequencing of DNA from
the samples was performed on a pyrosequencing
platform.¶¶
Primers used to amplify the 16S rRNA gene and to
introduce multiplex identifiers to identify amplicons
or samples are available on the National Institutes of
Health Human Microbiome Project website.15
The resulting fast files were preprocessed with
a quality control and data preprocessing tool16 by
size (more than 50 bp), quality (minimum quality
30), and N content (rejecting reads with >5% of Ns
and removing terminal Ns).
The reads were processed through metagenomic
rapid annotation using subsystems technology (MG-
RAST)17 based on hierarchical classification with the
Ribosomal Database Project (RDP; release 11). MG-
RAST default clustering parameters within the basic
local alignment search tool–like alignment tool al-
gorithm were used.
Each read was taxonomically assigned down to
the genus and species level with 80% confidence
threshold. Reads giving no bacterial hits were ex-
cluded. Artificial replicate sequences produced by
sequencing artifacts were removed.18
To estimate bacterial diversity, the number of
operational taxonomic units (OTUs) in the samples
was determined, and rarefaction analysis was per-
formed. Rarefaction curves were obtained by plotting
the number of observed OTUs against the number of
sequences, using the MG-RAST platform17 and the
RDP database.19,20
To estimate total diversity, sequences were clus-
tered at a standard threshold of 98% nucleotide
identity over a 90% sequence alignment length to
allow minimal flexibility and to minimize false posi-
tives. Rarefaction curves were obtained using the
RDP pyrosequencing pipeline (Fig. 1A). Venn anal-
ysis (Fig. 1B) and principal component analysis
(PCA) were performed, and heatmaps were gener-
ated using a statistical package.21 Venn analysis was
run on taxonomic diversity data. PCA analysis was
run on taxonomic diversity and abundance of each
individual sample and on the average of each group
(i.e., PG and HG) (Fig. 1C).
Microbial communities were compared by statis-
tical analysis using a distance metric matrix.22 This
analysis compares the 16S estimated diversity
through a phylogenetic approach that takes taxo-
nomically assigned and unassigned reads into ac-
count (Fig. 2). Heatmap analysis of taxonomic
diversity and abundance was done for each sample
(Fig. 3).
RESULTS
After extracting metagenomic data, quality of the
readings was assessed by a quality control tool.## Se-
quencing samples were of excellent quality (Phred
values >28). Unknown reads (not identified as rRNA
genes) varied among samples, ranging from 0.08% to
0.31%. Samples used in this study were deposited in the
GenBank under accession numbers SAMN06116059
to SAMN06116068.
Oral Microbial Community
The number of reads (filtered and assigned) and
number of taxonomic assignations (genus and spe-
cies) are listed in Table 1. Althoughmicrobiota-based
rarefaction curves (Fig. 1A) failed to reach saturation
phase, the slope of the curves become notably less
pronounced.
# QiAamp DNA minikit, Qiagen, Hilden, Germany.
** Qubit system, Thermo Fisher Scientific, Waltham, MA.
†† FastStart High Fidelity PCR Systems, Roche, Mannheim, Germany.
‡‡ GS Junior titanium sequencing kit, Roche.
§§ Agencourt AMPure beads, Beckman Coulter, Brea, CA.
ii Qubit dsDNA HS assay kit, Thermo Fisher Scientific.
¶¶ GS Junior platform, Roche Applied Science, Indianapolis, IN.
## FastQC pipelines, Babraham Bioinformatics, Babraham Institute,
Cambridge, U.K.
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Taxonomic results showed 96 different species: 55
common to both groups, 28 only found in PG, and 13
specific to HG (Figs. 1B and 4; Table 2). Both groups
showed homogeneous distribution (clearer in HG). The
heatmap (Fig. 3) clearly shows a number of species
with greater representation in the overall number of
bacteria, overexpressed particularly in HG.
The most abundant bacterial species among those
>5% of the total were as follows: 1) PG: Fusobacterium
nucleatum, Prevotella oris, Prevotella denticola, and
Prevotella melaninogenica; 2) HG: F. nucleatum, P.
melaninogenica, Rothia dentocariosa, P. oris, and
Veillonella parvula; and 3) overall: F. nucleatum, P. oris,
P. melaninogenica, R. dentocariosa, and P. denticola.
The most commonly found was F. nucleatum, over-
represented in HG. The genus Prevotella was the most
common overall, and P. denticola was overrepresented
in PG, with 13 times higher abundance than in HG.
Figure 1.
A) Rarefaction plot showing a curve of annotated species richness. This curve represents the total number of distinct species annotations as a function
of the number of sequences sampled. B) Venn diagram demonstrating bacterial taxonomic distribution between diseased and healthy samples. C) PCA
relationships among groups of samples. Circles include samples belonging to the same group.
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Sixteen of the bacteria found have been related to
microbial complexes of subgingival plaque4 (see sup-
plementary Table 1 in online Journal of Periodontology).
Bacteria from the green and purple clusters
seemed to be more numerous than others, except for
the above-mentioned bacteria and Campylobacter
showae (orange cluster).
Regarding differences between groups (Table 2),
periodontopathogens were not more prevalent in
PG than in HG. Moreover, Porphyromonas gingivalis
was only found in healthy individuals. In contrast, first
colonizers such as Streptococcus anginosus and
Streptococcus intermedius were only found in PG.
Of the 96 bacteria identified, 19 were not in the
Human Oral Microbiome Database (HOMD)23 or the
CORE Microbiome Database.24
DISCUSSION
Implant surfaces are designed to enhance osseointe-
gration. When bone remodeling or loss occurs and
areas of the implant surface become exposed to the
oral environment, saliva biopolymers form a film that
becomes the interface between the implant surface
and the first microorganisms. Many characteristics of
the titanium implant surface, such as roughness, hy-
drophobicity, and charge, affect bacterial adhesion.25
Figure 2.
Bacteriome cladogram with pyrosequencing datasets of the two groups of samples (PG and HG: pool 1 and pool 2). The RDP database20 was used as
the annotation source, and a minimum identity cutoff of 98% was applied. Colors for the genus branches are indicated in the taxa section of the key.
Bars in the external circle indicate abundance of the term in each sample. Colors of the samples are indicated in the samples section of the key.
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Figure 3.
Heatmap visualization of changes in bacterial diversity among groups (HG and PG, represented by individual samples).
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Figure 4.
Taxonomic spectrum visualized with Krona chart of counts in the metagenome. Circles represent taxonomic classifications in ascending order up to the
family level (outermost circle). Less abundant taxa are listed outside the charts together with their relative abundance. Data are obtained from raw data
using the MG-RAST server. A) PG samples pool. B) HG samples pool.
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The present study adds new information regarding
microbiota formed on implants when they become
exposed to the oral cavity without associated in-
flammation (i.e., in soft tissue recession or bone re-
modeling processes). These data can also be useful
when peri-implantitis patients are surgically treated
with a resective approach. In these cases, after surface
decontamination, an apically repositioned flap ismade
to reduce peri-implant pockets, thus exposing the
rough surface of the implant.
One of the main limitations of this study is the
reduced sample size, which may jeopardize gener-
alization of outcomes. Also, the fact that all samples
were collected after 14 days did not allow a study of
the evolution of biofilm formation.
Periodontal disease is a known risk factor for peri-
implantitis and one of the explanations, apart from
patient susceptibility, is that periodontally involved
teeth may act as a reservoir for periodontal pathogens
that can colonize the implant surface.26 However,
a study using an open-ended molecular approach
showed that in 85% of participants, <8% of species
were shared between teeth and implants, suggesting
that microbiology of peri-implantitis and periodontitis
might be quite different.27 Data from the present study,
although obtained from healthy sites, seem to support
these results, as species generally associated with
diseased implants, such as P. gingivalis, are detected
in healthy implants but only in periodontally healthy
individuals. P. gingivalis might have an important role
in peri-implant diseases as it has been described as an
‘‘enhancer species’’ that is involved in coaggregation
stages during biofilm maturation.28
On the other hand, many identified bacteria such
as Streptococcus sanguinis, Actinomyces naeslun-
dii, Campylobacter rectus, Parvimonas micra, and
Granulicatella adiacens or the genera Fusobacte-
rium,Actinomyces, Veillonella,Atopobium,Gemella,
Rothia, and Leptotrichia have been associated with
healthy implants in previous studies.8,28-30 Special
consideration should be taken with the genera Acti-
nomyces and Veillonella as most authors28,31 agreed
to finding them more frequently in healthy implants,
and none of the revised studies associate them with
peri-implantitis.8,28-33 Presence of these bacteria,
together with Streptococcus mitis and S. sanguinis,
may play a protective role regarding peri-implant
diseases.34,35
Prevotella spp. were found widely in both PG and
HG, and P. denticola was one of the most abundant
bacteria. It has been associated with periodontal
disease as strongly as the classic red complex,36 but it
should be remembered that patients in PG had PD
<4 mm and at least 70% of sites with no BOP.
Therefore, presence of this genus in both groups may
suggest that it is only pathogenic when the bacterial
balance is disturbed or when there is host suscepti-
bility.
Another most abundant bacterium was F. nucle-
atum. It is known to mediate between the first and
subsequent colonizers and interact with host cells,
facilitating coaggregation with periodontopathogens
such as P. gingivalis.37 Some authors suggest that
F. nucleatum infection facilitates attachment of P.
gingivalis to the gingival fibroblast, and consequently
these two bacteria are often found together.38 In-
terestingly, F. nucleatum was abundant in both groups
(15,404 in PG and 24,714 in HG), whereas P. gingivalis
was not identified in PG but had an abundance of 611
in HG.
Previous publications concluded that in peri-
odontally healthy individuals, P. gingivalis and Ag-
gregatibacter actinomycemcomitans were never39 or
rarely40 found on implants. The present study con-
tradicts this statement, as P. gingivalis was specifi-
cally found in HG. This disparity might be explained
by the different analytic method (pyrosequencing),
which in the authors’ opinion affords more complete
and detailed data gathering and should be im-
plemented more frequently in the future.
The microbiome surrounding teeth has been shown
to be significantly more diverse than that around im-
plants.41,42 In addition, the rate of traditional pathogens
around implants has been reported to be lower than that
around teeth in both healthy and diseased patients.43
Cortelli et al.43 also pointed out that early colonizers of
rough implant surfaces might constitute a different
bacterial microbiome from that of periodontal diseases.
The present report shows that individuals have an im-
portant variability regarding the composition of biofilm.
This indicates that studies with large samples are re-
quired. It would be interesting to analyze whether this
variability is related with the different progression pat-
terns of BL found in peri-implantitis.
Streptococcus, Granulicatella, and Gemella were
present in both PG and HG, in agreement with a pre-
vious study.44 These bacteria are considered symbi-
onts, with a high proportion returning to pockets after
periodontal treatments.45
Regarding differences among groups, special
mention should be made of four bacteria with >1%
abundance: Porphyromonas endodontalis, Prevotella
baroniae and an uncultured Porphyromonas sp. in PG
and Corynebacterium matruchotii in HG. P. endo-
dontalis is found in symptomatic oral infections, such
as endodontic infections and periodontal pockets, but
also in asymptomatic cases. It shows low virulence in
experimental monoinfections but seems to play an
important role in anaerobic mixed infections.46 P.
baroniae has been described as a causal agent of
endodontic abscesses.47 C. matruchotii is considered
part of normal oral microbiota.48
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High prevalence of Gram-negative bacteria in HG
and Gram-positive bacteria in PG is surprising, as
earlier studies demonstrated Gram-negative preva-
lence in oral microbioma.2
Although 19 bacteria were not registered in the
HOMD or CORE databases, five had been reported
previously, including Prevotella bergensis, Leptotrichia
sp. HKU24, and Prevotella copri. The remaining 14
have been identified in human infections in other areas
of the body or found in insects, contaminated water,
dogs, cats, or birds (see supplementary Table 1 in
online Journal of Periodontology). Contamination of
samples during transport was highly unlikely because
the snap-tubes were sterile, and the abutment did not
touch its walls (it was firmly screwed to a sterile implant
replica). Future research should examine whether these
microorganisms play an important role in peri-implant
diseases. This is quite an important finding, and once
again indicates the importance of using metagenomic
analysis techniques. Other microbiologic methods such
as checkerboard DNA–DNA hybridization are indeed
extremely accurate and have high sensitivity (>92.5%)
and specificity (100%), but are clearly insufficient to
detect composition of the microbiome surrounding
implants.49 Likewise, the sample collection method
might cause important discrepancies among studies.
Biofilms collected with curets can result in lower bac-
terial counts due to implant topography,11 and sterile
paper points can be a source of foreign bacteria.50 This
is an important advantage of the present method to
recover biofilm. Other authors have previously reported
use of abutments with different roughnesses51 for this
purpose, but with no threads. Thus, a study comparing
different biofilm sampling methods would be of interest.
CONCLUSIONS
A wide variety of bacteria (96 species) were found
around abutments simulating exposed dental im-
plants without inflammation in 10 individuals. The
most frequently found bacteria were F. nucleatum
and P. denticola. Some species generally associated
with periodontitis were more commonly found in
patients without history of periodontitis.
A large number of bacteria that had never been
described as part of the oral microbiome were found
in the present sample. Further research with larger
samples is needed to clarify the role of these mi-
croorganisms in the oral environment.
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